Updates in Malignant Biliary Tract Tumors

Pubblicato il: 15 November 2024

Brochure November 15-16, 2024

Updates in Malignant Biliary Tract Tumors

Biliary diseases, particularly cholangiocarcinomas, represent a clinical challenge due to their diagnostic and therapeutic complexity. The congress offers a multidisciplinary analysis ranging from anatomical and biomolecular classification, through advanced diagnostic techniques like radiomics and echoendoscopy, to the use of minimally invasive therapies and endoluminal radiotherapy.

Furthermore, the meeting includes sessions on mini-invasive and extreme surgical approaches, integrated with the use of 3D simulations for surgical planning.

 


 

PROGRAM

 

DAY I Friday, November 15, 2024

Chairperson: A. Pezzolla   Moderators: A. Facciorusso, S. Leo

  • 15:00 Participant Registration

  • 15:30 Introduction and Welcome Addresses

    Scientific Director M. Spampinato

  • 15:45 Omics and molecular sub-types: impact on therapeutic choices (Speaker M.Donadon)

  • 16:00 The role of radiomics (Speaker A. Scardapane)

  • 16:15 Advanced endoluminal diagnostics and endoscopic therapies (Speakers A. Dell’Anna, R.O. Leone)

  • 16:30 Coffee Break

  • 17:00 Echoendoscopy in the diagnosis of neoplastic diseases of the Biliary Tract (BT) (Speaker E. Stasi)

  • 17:15 Percutaneous approach to the biliary tract: when and with what objectives (Speaker R. Prudenzano)

  • 17:30 Discussion

  • 18:15 Closing of the training day

 

DAY II Saturday, November 16, 2024

Chairperson: M. Testini   Moderators: V. Chiuri, R. Memeo, C. Scavelli

  • 09:00 3D reconstructions and simulations in the planning of liver resections (Speaker A. Ruzzenente)
  • 09:15 Minimally invasive surgical therapy for hilar and intrahepatic cholangiocarcinoma and hypertrophy techniques: when and for which patients (Speaker F. Panaro)
  • 09:30 Minimally invasive surgical therapy for distal cholangiocarcinoma (Speaker S. D’Ugo)
  • 09:45 Extreme surgery and transplantation in hilar cholangiocarcinoma (Speaker U. Cillo)
  • 10:00 Coffee Break
  • 10:30 New perspectives in chemotherapy: conversion therapies and immunotherapy (Speaker V. Zurlo)
  • 10:45 Endoluminal radiotherapy (Speaker G.C. Mattiucci)
  • 11:00 Video forum: minimally invasive surgery in the treatment of cholangiocarcinomas
  • 11:30 Conclusion of the works and CME test
  • 12:00 End of event